139 related articles for article (PubMed ID: 8385409)
1. [Tumor properties of primary tumors and local recurrence of breast cancer].
Torsten U; Opri F; Moreno-Richter I; Weitzel HK
Zentralbl Gynakol; 1993; 115(3):99-104. PubMed ID: 8385409
[TBL] [Abstract][Full Text] [Related]
2. [The immunohistochemical growth fraction (Ki-67) of breast cancers: relations to tumor spread, tumor morphology and receptor testing].
Weikel W; Beck T; Rosenthal H; Herzog R
Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):277-82. PubMed ID: 2566552
[TBL] [Abstract][Full Text] [Related]
3. [Effect of the proliferation rate on the course of node negative breast carcinoma].
Mitze M; Weikel W; Brumm C; Lippold R; Knapstein PG
Geburtshilfe Frauenheilkd; 1995 Jun; 55(6):299-305. PubMed ID: 7657137
[TBL] [Abstract][Full Text] [Related]
4. [137 local recurrences after breast carcinoma--a retrospective study].
Richter IM; Opri F; Torsten U; Weitzel H
Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):198-203. PubMed ID: 8682285
[TBL] [Abstract][Full Text] [Related]
5. [Cathepsin D in primary breast cancer in correlation with various prognostic factors].
Rempen A; Caffier H
Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):272-5. PubMed ID: 1650323
[TBL] [Abstract][Full Text] [Related]
6. Hormonal receptors, cell proliferation fraction (Ki-67) and c-erbB-2 amplification in breast cancer. Relationship between differentiation degree and axillary lymph node metastases.
Sirvent JJ; Santafé M; Salvadó MT; Alvaro T; Raventós A; Palacios J
Histol Histopathol; 1994 Jul; 9(3):563-70. PubMed ID: 7526910
[TBL] [Abstract][Full Text] [Related]
7. [Cell receptors and proliferation markers in breast cancer].
Czerwenka KF; Schön HJ; Zeillinger R; Kubista E; Spona J
Gynakol Rundsch; 1989; 29 Suppl 2():400-1. PubMed ID: 2558992
[No Abstract] [Full Text] [Related]
8. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
9. [Progesterone receptors in breast cancer. Comparison of immunohistochemical with biochemical receptor analysis. Relation between hormone receptor content and growth fraction (Ki-67)].
Ronay G; Sponsel N; Merkle E; Tulusan AH
Pathologe; 1990 Jan; 11(1):4-9. PubMed ID: 2156252
[No Abstract] [Full Text] [Related]
10. PCNA/cyclin expression in breast carcinomas: its relationships with Ki-67, ER, PgR immunostainings and clinico-pathologic aspects.
Tuccari G; Rizzo A; Muscarà M; Giuffrè G; Barresi G
Pathologica; 1993; 85(1095):47-55. PubMed ID: 8100059
[TBL] [Abstract][Full Text] [Related]
11. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
Saha B; Zhang N; Naritoku WY; Tsao-Wei DD; Groshen SL; Carlsson G; Larsson L; Gustavsson B; Chaiwun B; Taylor CR; Imam SA
Anticancer Res; 2004; 24(4):2391-400. PubMed ID: 15330189
[TBL] [Abstract][Full Text] [Related]
12. [Grading, staging, DNA content and prognosis of invasive ductal breast cancer].
Theissig F; Kunze KD; Haroske G; Meyer W; Dimmer V
Zentralbl Chir; 1990; 115(7):433-9. PubMed ID: 2164288
[TBL] [Abstract][Full Text] [Related]
13. Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
Depowski PL; Rosenthal SI; Brien TP; Stylos S; Johnson RL; Ross JS
Mod Pathol; 2000 May; 13(5):542-7. PubMed ID: 10824926
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women.
Temmim L; Baker H; Sinowatz F
Anticancer Res; 2001; 21(1B):743-8. PubMed ID: 11299837
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors in medullary breast cancer].
Mitze M; Goepel E
Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):635-41. PubMed ID: 2777051
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors in breast cancer and their consequences for therapeutic decisions].
Graeff H; Jänicke F
Chirurg; 1992 Jun; 63(6):461-8. PubMed ID: 1643982
[No Abstract] [Full Text] [Related]
17. The prognostic significance of multiple morphologic features and biologic markers in ductal carcinoma in situ of the breast: a study of a large cohort of patients treated with surgery alone.
Cornfield DB; Palazzo JP; Schwartz GF; Goonewardene SA; Kovatich AJ; Chervoneva I; Hyslop T; Schwarting R
Cancer; 2004 Jun; 100(11):2317-27. PubMed ID: 15160334
[TBL] [Abstract][Full Text] [Related]
18. Primary tumour characteristics and axillary lymph node status in breast cancer.
Yiangou C; Shousha S; Sinnett HD
Br J Cancer; 1999 Aug; 80(12):1974-8. PubMed ID: 10471048
[TBL] [Abstract][Full Text] [Related]
19. Flt-4-positive vessel density correlates with vascular endothelial growth factor-d expression, nodal status, and prognosis in breast cancer.
Nakamura Y; Yasuoka H; Tsujimoto M; Yang Q; Imabun S; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Clin Cancer Res; 2003 Nov; 9(14):5313-7. PubMed ID: 14614015
[TBL] [Abstract][Full Text] [Related]
20. [Combined surgery and radiotherapy in the treatment of ductal carcinoma in situ of the breast: preliminary results of the Hungarian multicenter prospective randomised study].
Polgár C; Orosz Z; Kahán Z; Gábor G; Jani N; Cserni G; Hadijev J; Kulka J; Sulyok Z; Boross G; Lázár G; László Z; Diczházi C; Udvarhelyi N; Szabó E; Péntek Z; Major T; Fodor J
Magy Onkol; 2008 Sep; 52(3):269-77. PubMed ID: 18845497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
